EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Early and late outcomes after aortic valve replacement, mitral valve replacement and mitral valve plasty for native and prosthetic valve endocarditis in The Netherlands

Floris J Heinen iD, Annelot J L Peijster, Edouard L Fu, Otto Kamp iD, Steven A J Chamuleau iD, Marco C Post iD, Michelle D van der Stoel, Mohammed-Ali Keyhan-Falsafi, Cees van Nieuwkoop iD, Jesper Hjortnaes iD, Robert J M Klautz iD, Wilco Tanis und 1 weitere

European Heart Journal - Imaging Methods and Practice · 01.01.2026 · 4 (1)

DOI: 10.1093/ehjimp/qyag093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal - Imaging Methods and Practice, online erschienen am 19.05.2026. Verfasst von Floris J Heinen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Haga Teaching Hospital, Els Borst-Eilersplein 275, The Hague 2545 AA, the Netherlands. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of this nationwide descriptive study is to assess short-, mid-, and long-term mortality risk following aortic valve replacement (AVR), mitral valve replacement (MVR) and mitral valve plasty (MVP) in patients with native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE). Mortality outcomes were also evaluated for biological and mechanical valve prostheses. Methods and results Patients with infective endocarditis who underwent AVR, MVR, or MVP between 2013 and 2022 were included from the Netherlands Heart Registration. Patients were excluded in case of combined valve surgery, aortic root replacement, a history of non-valvular cardiac surgery followed by NVE and unclear surgical history precluding confirmation of PVE. Descriptive analyses were performed, and mortality risks were estimated using Kaplan-Meier analysis. 1810 patients were included, of whom 75.4% had NVE and 24.6% PVE. In NVE, short-term mortality was highest after MVR (13.2%), followed by AVR (4.6%) and MVP (3.8%). Long-term mortality risks were 32.1%, 22.3%, and 11.5%, respectively. In PVE, short-term mortality risk was highest in AVR (10.2%), followed by MVR (7.6%) and MVP (5.0%). Long-term mortality risks were 27.3%, 31.7% and 35.2%, respectively. Short-term mortality was similar between patients receiving biological and mechanical prosthesis in the AVR and MVR groups, whereas long-term mortality was higher among those who received biological prostheses.

Conclusion

This nationwide study shows that mortality after cardiac surgery for infective endocarditis considerably varies by valve and prosthesis type. In NVE, mortality was highest after MVR. In PVE, outcomes were comparable across procedures. Long-term mortality was lowest with mechanical prostheses.

Schlagwörter

Stichwörter der Autor:innen

aortic valve replacementinfective endocarditislong-term mortality riskmitral valve plastymitral valve replacementmortality outcome

Autor:innen und Institutionen

  • Department of Cardiology, Haga Teaching Hospital, Els Borst-Eilersplein 275, The Hague 2545 AA, the Netherlands.
  • Department of Cardiology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Cardiology, St.Antonius Hospital, Nieuwegein, the Netherlands.
  • Department of Cardiology, Utrecht University Medical Center, Utrecht, the Netherlands.
  • Netherlands Heart Registration, Utrecht, the Netherlands.

ORCID-Profile: Floris J Heinen, Otto Kamp, Steven A J Chamuleau, Marco C Post, Cees van Nieuwkoop, Jesper Hjortnaes, Robert J M Klautz

Zitieren

APA

Heinen, F. J., Peijster, A. J. L., Fu, E. L., Kamp, O., Chamuleau, S. A. J., Post, M. C., van der Stoel, M. D., Keyhan-Falsafi, M. A., van Nieuwkoop, C., Hjortnaes, J., Klautz, R. J. M., Tanis, W., & Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration (2026). Early and late outcomes after aortic valve replacement, mitral valve replacement and mitral valve plasty for native and prosthetic valve endocarditis in The Netherlands. European Heart Journal - Imaging Methods and Practice, 4(1). https://doi.org/10.1093/ehjimp/qyag093

Vancouver

Heinen FJ, Peijster AJL, Fu EL, Kamp O, Chamuleau SAJ, Post MC, et al. Early and late outcomes after aortic valve replacement, mitral valve replacement and mitral valve plasty for native and prosthetic valve endocarditis in The Netherlands. European Heart Journal - Imaging Methods and Practice. 2026;4(1). doi:10.1093/ehjimp/qyag093

BibTeX
@article{Heinen2026,
  author = {Heinen, Floris J and Peijster, Annelot J L and Fu, Edouard L and Kamp, Otto and Chamuleau, Steven A J and Post, Marco C and van der Stoel, Michelle D and Keyhan-Falsafi, Mohammed-Ali and van Nieuwkoop, Cees and Hjortnaes, Jesper and Klautz, Robert J M and Tanis, Wilco and Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration, Cardiothoracic Surgery Registration Committee of the Netherlands Heart Registration},
  title = {Early and late outcomes after aortic valve replacement, mitral valve replacement and mitral valve plasty for native and prosthetic valve endocarditis in The Netherlands},
  journal = {European Heart Journal - Imaging Methods and Practice},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.1093/ehjimp/qyag093}
}
Kostenlos starten →